Pembrolizumab Combined With Cisplatin-based Chemotherapy as First-line Systemic Therapy in Advanced Penile Cancer (HERCULES)
Condition: Penile Carcinoma Interventions: Drug: Pembrolizumab; Drug: Standard of care therapy Sponsors: Latin American Cooperative Oncology Group; Merck Sharp & Dohme Corp. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 13, 2020 Category: Research Source Type: clinical trials
Cabozantinib in Patients With Advanced Penile Squamous Cell Carcinoma (PSCC) (CaboPen)
Condition: Penile Squamous Cell Carcinoma Intervention: Drug: Cabozantinib Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 9, 2019 Category: Research Source Type: clinical trials